SSTR5 Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P35346 |
---|---|
Clone Names | 100617310 |
Gene ID | 6755 |
---|---|
Other Names | Somatostatin receptor type 5, SS-5-R, SS5-R, SS5R, SSTR5 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | SSTR5 |
---|---|
Function | Receptor for somatostatin 28 and to a lesser extent for somatostatin-14. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. Increases cell growth inhibition activity of SSTR2 following heterodimerization. |
Cellular Location | Cell membrane; Multi-pass membrane protein. |
Tissue Location | Adult pituitary gland, heart, small intestine, adrenal gland, cerebellum and fetal hypothalamus. No expression in fetal or adult kidney, liver, pancreas, uterus, spleen, lung, thyroid or ovary. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Somatostatin and its related peptide cortistatin exertmultiple biological actions on normal and tumoral tissue targets byinteracting with somatostatin receptors (SSTRs). The proteinencoded by this gene is one of the SSTRs, which is a multi-passmembrane protein and belongs to the G-protein coupled receptor 1family. The activity of this receptor is mediated by G proteinswhich inhibit adenylyl cyclase, and different regions of thisreceptor molecule are required for the activation of differentsignaling pathways. A mutation in this gene results in somatostatinanalog resistance. Alternatively spliced transcript variants havebeen identified in this gene.
References
Canzian, F., et al. Hum. Mol. Genet. 19(19):3873-3884(2010)Saus, E., et al. J Psychiatr Res 44(14):971-978(2010)Pinheiro, A.P., et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (5), 1070-1080 (2010) :Duran-Prado, M., et al. J. Clin. Endocrinol. Metab. 95(5):2497-2502(2010)Pisarek, H., et al. Folia Histochem. Cytobiol. 48(1):142-147(2010)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.